Stevanato Group S.p.A. (STVN): Price and Financial Metrics Recent IPO


Stevanato Group S.p.A. (STVN): $26.92

0.03 (+0.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

STVN Stock Price Chart Interactive Chart >

Price chart for STVN

STVN Price/Volume Stats

Current price $26.92 52-week high $28.66
Prev. close $26.89 52-week low $16.61
Day low $26.75 Volume 340,900
Day high $27.80 Avg. volume 855,167
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap 7.94B

Stevanato Group S.p.A. (STVN) Company Bio


Stevanato Group S.p.A. engages in the design, production, and distribution of products and systems to provide integrated solutions for pharma and healthcare. Its principal products are linked to containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machine. Stevanato Group S.p.A. was founded in 1949 and is based in Piombino Dese, Italy.


STVN Latest News Stream


Event/Time News Detail
Loading, please wait...

STVN Latest Social Stream


Loading social stream, please wait...

View Full STVN Social Stream

Latest STVN News From Around the Web

Below are the latest news stories about Stevanato Group SpA that investors may wish to consider to help them evaluate STVN as an investment opportunity.

Vaccine vial maker Stevanato to fund new plants, M&A with IPO money -chairman

Italian vaccine vials maker Stevanato Group will use funds raised from its recent listing on the New York Stock Exchange to increase production capacity and for selected acquisitions, its executive chairman told Reuters on Thursday. According to its own estimates, it provides vials to about 90% of currently marketed COVID-19 vaccine programs. The medical packaging company raised $453.5 million in its July IPO and aims to build two new plants, which will focus on its high-margin products, including a drug containment solution called EZ-Fill.

Yahoo | August 19, 2021

Stevanato Group Announces Second Quarter 2021 Financial Results

PIOMBINO DESE, Italy, August 19, 2021--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the second quarter 2021 and established full-year 2021 guidance.

Yahoo | August 19, 2021

Stevanato Group to Report Second Quarter Financial Results on August 19

PIOMBINO DESE, Italy, August 11, 2021--Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced that it will issue financial results for the second quarter of fiscal year 2021 on Thursday, August 19, 2021.

Yahoo | August 11, 2021

7 Companies Opened for Trading. Here’s How They Did.

The group is diverse—a fintech, three biotechs, a real-estate investment manager, a bioscience company, and a pharmaceutical glassmaker.

Yahoo | July 16, 2021

Vaccine vial maker Stevanato valued at over $5 billion in tepid NYSE debut

(Reuters) -Italy's Stevanato Group S.p.A. made a tepid debut on the New York Stock Exchange as its shares slid, giving the world's second largest glass vial maker a valuation of $5 billion. Stevanato's shares fell more than 20% to open at $16.65 on Friday. "IPO is the best way to further finance the business...most of the proceeds of the IPO, we are going to invest in the new greenfield plants, one in Indiana, and one in China," said Franco Stevanato, executive chairman of the company's board.

Yahoo | July 16, 2021

Read More 'STVN' Stories Here

STVN Price Returns

1-mo 4.62%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7185 seconds.